Alectinib hydrochloride is a hydrochloride salt form of alectinib, a selective inhibitor of anaplastic lymphoma kinase (ALK). It is used as a pharmaceutical raw material for the manufacturing of medications indicated for ALK-positive metastatic non-small cell lung cancer.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1256589-74-8
Alectinib
active pharmaceutical ingredient
8-AZAGUANINE
antineoplastic agent
Chimmitecan
antineoplastic agent
Ixabepilone
antineoplastic agent
Duocarmycin DM free base
antineoplastic agent
(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[(2S)-2-[[1,1,1,3,3,3-hexadeuterio-2-(trideuteriomethyl)propan-2-yl]carbamoylamino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide
active pharmaceutical ingredient
Prochlorperazine edisylate
active pharmaceutical ingredient
Venetoclax
active pharmaceutical ingredient
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile;hydrochloride
GYABBVHSRIHYJR-UHFFFAOYSA-N
CCC1=CC2=C(C=C1N3CCC(CC3)N4CCOCC4)C(C5=C(C2=O)C6=C(N5)C=C(C=C6)C#N)(C)C.Cl